FOX BIZ NEWS: Remdesivir data showing ‘meaningful benefits’: Biotech analyst


Remdesivir data showing ‘meaningful benefits’: Biotech analyst



Piper Sandler senior biotech analyst Tyler Van Buren argues the FDA will be under a lot of pressure to approve remdesivir under an accelerated timeline based on the data.

Comments

Post a Comment

Popular posts from this blog